SG49228A1 - Use of 2-amino-6-A-propyl-amino-4,5,6,7- tetrahydrobenzothiazole(pramipexol) as a antidepressant activity - Google Patents

Use of 2-amino-6-A-propyl-amino-4,5,6,7- tetrahydrobenzothiazole(pramipexol) as a antidepressant activity

Info

Publication number
SG49228A1
SG49228A1 SG1996007972A SG1996007972A SG49228A1 SG 49228 A1 SG49228 A1 SG 49228A1 SG 1996007972 A SG1996007972 A SG 1996007972A SG 1996007972 A SG1996007972 A SG 1996007972A SG 49228 A1 SG49228 A1 SG 49228A1
Authority
SG
Singapore
Prior art keywords
amino
pramipexol
tetrahydrobenzothiazole
propyl
antidepressant activity
Prior art date
Application number
SG1996007972A
Other languages
English (en)
Inventor
Rudolf Hammer
Joachim Mierau
Erich Lehr
Franco Borsini
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of SG49228A1 publication Critical patent/SG49228A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SG1996007972A 1992-12-05 1993-12-02 Use of 2-amino-6-A-propyl-amino-4,5,6,7- tetrahydrobenzothiazole(pramipexol) as a antidepressant activity SG49228A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4241013A DE4241013A1 (de) 1992-12-05 1992-12-05 Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung

Publications (1)

Publication Number Publication Date
SG49228A1 true SG49228A1 (en) 1998-05-18

Family

ID=6474503

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996007972A SG49228A1 (en) 1992-12-05 1993-12-02 Use of 2-amino-6-A-propyl-amino-4,5,6,7- tetrahydrobenzothiazole(pramipexol) as a antidepressant activity

Country Status (29)

Country Link
US (1) US6191153B1 (bg)
EP (1) EP0675717B1 (bg)
JP (1) JP3221880B2 (bg)
KR (1) KR100311165B1 (bg)
CN (1) CN1052400C (bg)
AT (1) ATE183091T1 (bg)
AU (1) AU674378B2 (bg)
BG (1) BG62475B1 (bg)
CA (1) CA2150131C (bg)
CZ (1) CZ282679B6 (bg)
DE (2) DE4241013A1 (bg)
DK (1) DK0675717T3 (bg)
ES (1) ES2136725T3 (bg)
FI (1) FI952734A0 (bg)
GR (1) GR3031521T3 (bg)
HK (1) HK1019003A1 (bg)
HU (1) HU221014B1 (bg)
IL (1) IL107870A (bg)
MX (1) MX9307644A (bg)
NO (1) NO306930B1 (bg)
NZ (1) NZ258876A (bg)
PL (1) PL309282A1 (bg)
RU (1) RU2157685C2 (bg)
SG (1) SG49228A1 (bg)
SK (1) SK281441B6 (bg)
TW (1) TW362973B (bg)
UA (1) UA35604C2 (bg)
WO (1) WO1994013287A1 (bg)
ZA (1) ZA939065B (bg)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156777A (en) 1994-12-15 2000-12-05 Pharmacia & Upjohn Company Use of pramipexole as a neuroprotective agent
US5650420A (en) * 1994-12-15 1997-07-22 Pharmacia & Upjohn Company Pramipexole as a neuroprotective agent
US6001861A (en) 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
DE19830201A1 (de) * 1998-07-07 2000-01-13 Boehringer Ingelheim Pharma Mittel mit antidepressiver Wirkung
CA2301899C (en) * 1998-07-27 2008-11-18 Boehringer Ingelheim Pharma Kg Agent with an antidepressant activity
PE20011074A1 (es) 2000-02-23 2001-10-04 Upjohn Co Uso de pramipexol en el tratamiento de trastornos de adiccion
CA2415815A1 (en) * 2000-07-06 2002-01-17 Nigel H. Greig Tetrahydrobenzothiazole analogues as neuroprotective agents
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
EP1260221A3 (en) * 2001-05-23 2002-12-18 Pfizer Products Inc. Combination treatment for depression and anxiety
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
MY142204A (en) * 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
DE102004006808A1 (de) 2004-02-11 2005-09-01 Grünenthal GmbH Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen
CA2576386A1 (en) * 2004-08-13 2006-02-16 Boehringer Ingelheim International Gmbh Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
PL1789021T3 (pl) * 2004-08-13 2012-04-30 Boehringer Ingelheim Int Preparat tabletkowy o przedłużonym uwalnianiu zawierający pramipeksol lub jego farmaceutycznie dopuszczalną sól
EP1867641A4 (en) * 2005-04-04 2010-01-13 Takeda Pharmaceutical A PROPHYLACTIC OR THERAPEUTIC MEDICINE AGAINST AQUEOUS DEPRESSION OR NEUROSIS
EP1940398A1 (de) * 2005-10-18 2008-07-09 Boehringer Ingelheim International GmbH Verwendung von pramipexol zur behandlung des moderaten bis schweren restless legs syndroms (rls)
US20090041844A1 (en) * 2006-02-10 2009-02-12 Boehringer Ingelheim International Gmbh Modified Release Formulation
US20090098202A1 (en) * 2006-02-10 2009-04-16 Boehringer Ingelheim International Gmbh Extended Release Formulation
BR112019021125A2 (pt) * 2017-04-10 2020-05-12 Chase Therapeutics Corporation Combinação de antagonista de nk1 e método para tratamento de sinucleinopatias
MA49524A (fr) 2017-06-30 2021-05-26 Chase Therapeutics Corp Compositions d'antagoniste de nk-1 et méthodes destinées à être utilisées dans le traitement de la dépression
CN108802584B (zh) * 2018-06-29 2020-12-08 广东工业大学 一种变压器绝缘纸老化状态评估方法
TWI672472B (zh) * 2018-08-15 2019-09-21 鄭映芳 飲料製冰機裝置
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0186087B1 (de) * 1984-12-22 1989-08-23 Dr. Karl Thomae GmbH Tetrahydro-benzthiazole, deren Herstellung und deren Verwendung als Zwischenprodukte oder als Arnzneimittel
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
DE3930282A1 (de) * 1989-09-11 1991-03-21 Boehringer Ingelheim Kg Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit

Also Published As

Publication number Publication date
PL309282A1 (en) 1995-10-02
MX9307644A (es) 1994-06-30
DE4241013A1 (de) 1994-06-09
IL107870A0 (en) 1994-04-12
AU674378B2 (en) 1996-12-19
NO306930B1 (no) 2000-01-17
TW362973B (en) 1999-07-01
DE59309733D1 (de) 1999-09-16
UA35604C2 (uk) 2001-04-16
CZ282679B6 (cs) 1997-08-13
EP0675717B1 (de) 1999-08-11
HUT71798A (en) 1996-02-28
CA2150131A1 (en) 1994-06-23
GR3031521T3 (en) 2000-01-31
JP3221880B2 (ja) 2001-10-22
CZ144095A3 (en) 1996-03-13
CN1052400C (zh) 2000-05-17
NZ258876A (en) 1997-07-27
WO1994013287A1 (de) 1994-06-23
HU9501623D0 (en) 1995-08-28
FI952734A (fi) 1995-06-05
US6191153B1 (en) 2001-02-20
NO952207L (no) 1995-06-02
AU5715294A (en) 1994-07-04
HK1019003A1 (en) 2000-01-14
SK281441B6 (sk) 2001-03-12
CN1091635A (zh) 1994-09-07
BG62475B1 (bg) 1999-12-30
NO952207D0 (no) 1995-06-02
ES2136725T3 (es) 1999-12-01
SK74095A3 (en) 1996-05-08
JPH08504201A (ja) 1996-05-07
CA2150131C (en) 2004-09-21
EP0675717A1 (de) 1995-10-11
DK0675717T3 (da) 2000-02-28
KR950703953A (ko) 1995-11-17
HU221014B1 (hu) 2002-07-29
FI952734A0 (fi) 1995-06-05
BG99700A (bg) 1996-04-30
RU2157685C2 (ru) 2000-10-20
ZA939065B (en) 1994-08-04
ATE183091T1 (de) 1999-08-15
KR100311165B1 (ko) 2001-12-28
IL107870A (en) 1996-12-05

Similar Documents

Publication Publication Date Title
SG49228A1 (en) Use of 2-amino-6-A-propyl-amino-4,5,6,7- tetrahydrobenzothiazole(pramipexol) as a antidepressant activity
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
EG18729A (en) Compound of n- amino - 1,2,4-triazinones used as insecticide.
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
HUT67742A (en) Phosphono-oxymethyl-ethers of taxane derivatives
PH23778A (en) Labdan compounds,pharmaceutical compositions and use
ZA851552B (en) Benzisoselenazolethiones,processes for their preparation and pharmaceutical products containing these compounds
UA39101C2 (uk) ПОХІДНІ 11<font face="Symbol">b</font>-БЕНЗАЛЬДОКСИМ-ЕСТРА-4,9-ДІЄНУ, СПОСІБ ЇХ ОДЕРЖАННЯ І ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З АНТИПРОГЕСТИНОВОЮ АКТИВНІСТЮ
ZA9110018B (en) 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity.
IL111966A0 (en) 4-Benzoylisoxazole derivatives, their preparation and herbicidal compositions containing them
DK0719276T3 (da) Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf
IL158356A0 (en) Benzoheterocycles
CS318690A3 (en) Pharmaceutical composition usable for depression therapy
EG19425A (en) New compound of n-amino-1,2,4- triazinones their use as pesticide.
IL85560A (en) Pharmaceutical compositions containing an antidepressant of the structural type of 10,11-dihydrodibenzo(b,f)azepine,a dibenzo-(a,d)(1,4)cycloheptadiene and/or a 10,11-dihydro-benzo-(b,f)oxepine and a pyrolidinone derivative
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
MY104318A (en) Novel thiopen compounds and their preparation
UA19097A (uk) D-1-ФЕHІЛ-2-МЕТИЛАМІHОПРОПАHОЛА 1-5,6,7-ТРИОКСИФЛАВОH-7-0-beta-D-ГЛЮКУРОHИДАТ, ЩО МАЄ ОКИСЛЮВАЛЬHУ ДІЮ ТА РОЗШИРЮЄ СУДИHИ
JO1711B1 (en) Therapeutic agents
UA11675A1 (uk) 1-БЕtА-ОКСИЕТИЛАМІHО-3-КЕТО-5,5-ДИМЕТИЛЦИКЛОГЕКСЕH -1, ЯКИЙ МАЄ АHАЛЬГЕТИЧHУ АКТИВHІСТЬ
UA16651A1 (uk) 1-1-феhил-2-метиламіhопропаhолу-1, 5, 6, 7-тріоксифлавоh-7-0-b-d-глюкуроhідат, що має аhтистресову активhість
UA16652A1 (uk) Д-проліл-феhілалаhілгліциhамід гідрохлорид, який має аhтидепресивhу, аhтиамhестичhу та аhтигіпоксичhу активність
UA19167A1 (uk) Гербіцидhа композиція